Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by HCallahann44on Jan 23, 2020 10:33am
113 Views
Post# 30588530

RE:RE:RE:RE:Ok found the bear case for ONCY on seeking alpha

RE:RE:RE:RE:Ok found the bear case for ONCY on seeking alphaMaybe so ---but the reason I like to invest in junior pm companies is because they can have serious home run power...ONCY seems to share that potential...but its strange to see bullish folks like CPAC etc...trimming their positions when the price pushes over 5....why would they do that? CPAC seemed to say he did it because he was making too much money and his ONCY holdings were becoming too big a percentage of his portfolio...isn't that the whole point here...to make a killing? I cant really find much negative about this stock other than the cash burn....yet it continues to languish far below the take out price assigned to lesser competitors...I have some dry powder but until I can get an answer to why its at these levels ... I will keep the powder dry.....
Bullboard Posts